Every batch ships straight from the lab that synthesises it — sealed, tamper-evident, and HPLC-verified to >99% purity . Buying direct means you pay the lab-direct rate on every vial, with nothing stacked on top.

Order a full sealed 10-vial research pack for a complete study supply, or add a single-vial sample alongside your pack to trial a new compound first. Same lab, same batch, same verified purity — scaled to whatever your research needs.

What It's Researched For

In plain terms, Adamax is Semax with a chemical anchor bolted on to make it last longer. Here is what that means for research, and where the honest limits are.

Structure-activity comparison

Its main research value is as a direct comparator against unmodified Semax — same core sequence, two deliberate stability modifications.

Lipophilic-modification studies

A worked example of adamantane conjugation, a strategy borrowed from CNS small molecules like amantadine and memantine.

Semax-family signalling

The underlying ACTH(4-10) pharmacophore is studied for BDNF expression and TrkB-related neurotrophic signalling.

Early-stage characterisation

Genuinely uncharacterised — the open work here is basic stability, solubility and binding profiling, not confirmatory studies.

Overview

In short: Adamax is a synthetic Semax-family research peptide: an N-acetylated ACTH(4-10) analogue carrying a C-terminal adamantane modification, designed for greater metabolic stability than unmodified Semax.

Key research facts

Built on the Semax (ACTH(4-10)) pharmacophore studied for BDNF and TrkB-related signalling

N-terminal acetylation intended to slow aminopeptidase degradation

C-terminal adamantane cage intended to raise lipophilicity and metabolic stability

Adamantane is a well-precedented CNS scaffold, used in amantadine and memantine

Of interest as a structure-activity comparator against unmodified Semax

Research use only. These points summarise lab themes, not human outcomes.

To understand Adamax you first have to understand Semax. Semax is a heptapeptide analogue of the ACTH(4-10) fragment — Met-Glu-His-Phe-Pro-Gly-Pro — developed within the Russian regulatory-peptide research programme and studied over several decades for effects on BDNF expression and TrkB-related neurotrophic signalling in the central nervous system. It has a real, if regionally concentrated, research literature behind it.

Adamax takes that scaffold and adds two deliberate stability modifications: acetylation at the N-terminus, intended to slow degradation by aminopeptidases, and an adamantane cage at the C-terminus. Adamantane is a rigid diamondoid hydrocarbon, highly lipophilic, and a well-precedented scaffold in central-nervous-system chemistry — it is the structural core of amantadine and memantine, where it is used precisely to improve stability and membrane partitioning. The design rationale for Adamax is therefore easy to state: preserve the Semax pharmacophore while extending its residence time.

Where honesty is required is on evidence. Adamax has no meaningful peer-reviewed literature of its own. There are no published pharmacokinetic data, no controlled studies in any species, and no independent confirmation that the intended stability gains are actually realised. Its available characterisation comes from supplier documentation rather than the scientific record, and researchers should verify the material specification against their own analysis. It is supplied here as a research-grade lyophilised powder for in-vitro and preclinical use only, and nothing on this page is medical advice.

Mechanism of Action

Adamax has no directly studied mechanism. Its presumed activity is inherited from the Semax / ACTH(4-10) pharmacophore — BDNF and TrkB-related neurotrophic signalling and melanocortin-receptor engagement — with the acetyl and adamantane modifications intended to alter pharmacokinetics rather than the target profile.

Pathway Effect Why it matters ACTH(4-10) pharmacophore Retains the Semax core sequence believed to carry the activity The basis for expecting any Semax-like behaviour at all BDNF / TrkB signalling Semax is studied for BDNF expression and TrkB-related neurotrophic signalling Inherited hypothesis — not demonstrated for Adamax itself N-terminal acetylation Intended to slow aminopeptidase cleavage at the amino terminus A standard, well-understood peptide stabilisation strategy C-terminal adamantane Adds a rigid lipophilic cage intended to raise stability and membrane partitioning Precedented in CNS chemistry (amantadine, memantine); unverified here

Deeper dive for scientific readers

Every mechanistic statement that can be made about Adamax is inferential. The reasoning runs: Semax is studied for BDNF and TrkB-related signalling; Adamax retains the Semax core; therefore Adamax may behave similarly with a longer duration. That chain is plausible medicinal chemistry but it is not evidence. Adamantane conjugation is genuinely well-precedented for improving metabolic stability and lipophilicity, and N-terminal acetylation is a standard aminopeptidase-blocking strategy — but bulky C-terminal modifications can also interfere with target binding, and whether this particular conjugate preserves the pharmacophore has not been published. No binding data, no stability data, no pharmacokinetic data and no in-vivo comparison against Semax appear in the peer-reviewed literature. For research purposes Adamax should be treated as an uncharacterised structural analogue: interesting as a comparator, not as a validated tool compound.

Common Questions People Are Asking

What is Adamax used for in research?

Its clearest research use is as a structure-activity comparator against unmodified Semax — same core ACTH(4-10) pharmacophore, two deliberate stability modifications. Beyond that, basic characterisation work (stability, solubility, binding) is genuinely open, because none of it has been published. It is supplied here for laboratory research only and is not for human use.

How does Adamax differ from Semax?

Adamax retains the Semax core sequence but adds an N-terminal acetyl group, intended to slow aminopeptidase degradation, and a C-terminal adamantane cage, intended to increase lipophilicity and metabolic stability. The design goal is a longer-lasting Semax. Whether that goal is achieved has not been demonstrated in published work.

Why does adamantane appear in a peptide?

Adamantane is a rigid, highly lipophilic diamondoid hydrocarbon with a long track record in central-nervous-system drug design — it is the structural core of amantadine and memantine, where it improves stability and membrane partitioning. Conjugating it to a peptide is a recognised strategy for the same purpose, though bulky terminal groups can also interfere with target binding.

Is there human clinical data for Adamax?

No. There are no controlled human studies, no published pharmacokinetic parameters and no peer-reviewed literature on Adamax at all. The indirect support comes from the Semax scaffold it is built on and from adamantane conjugation as a general medicinal-chemistry strategy — neither of which is evidence about this specific molecule. Treat it as an uncharacterised research compound.

How should Adamax be stored?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water or sterile saline, refrigerate at 1–6 °C and protect from light. Because its stability profile is unpublished, aliquot after reconstitution and avoid repeated freeze-thaw cycles where the protocol allows.

Where can I buy Adamax?

Right here — Adamax is supplied directly by New-U Research Compounds on this page. Every batch is independently third-party tested to >99% HPLC purity with a batch-linked Certificate of Analysis, supplied as lyophilised research-grade material, and shipped direct from source worldwide in discreet, tracked packaging. Strictly for laboratory research use only — not for human use.

How much does Adamax cost?

Adamax pricing is shown live on this page, per pack size — 10-vial research packs as standard, with single-vial sample options on selected compounds. Larger vial strengths lower the per-mg cost, every order includes the batch Certificate of Analysis, and shipping is free on orders over $300.

Is Adamax third-party tested?

Yes. Every Adamax batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC. Every order ships with its COA, and current batch certificates are published on our COA page.

How do I buy Adamax?

Add the Adamax pack size you need to your cart and check out: enter your shipping details, then choose your payment method — cryptocurrency or card — on the next step. Every order ships with its batch Certificate of Analysis (COA). Adamax is supplied strictly for laboratory research use only, not for human or veterinary use.

What payment methods can I use to buy Adamax?

At checkout you can pay by cryptocurrency (BTC, ETH, SOL, LTC, USDC, USDT and more) or by card, each handled by a dedicated secure payment provider. You choose your method after confirming your order.

How fast is shipping, and do you ship worldwide?

Yes — we ship worldwide in discreet, unmarked, temperature-stable, tracked packaging. Delivery typically takes 6–14 business days, and shipping is free on orders over $300.

Is it legal to buy Adamax?

In the United States, Adamax is sold strictly for laboratory and research purposes only. It is not approved by the FDA for human consumption and is not sold for that purpose. Regulatory status varies by jurisdiction — buyers are responsible for compliance in their own region.

Pharmacokinetics

Stability Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. Notes There are no published pharmacokinetic parameters for Adamax: half-life, volume of distribution, bioavailability and central penetration are all uncharacterised. The design intent of the acetyl and adamantane modifications is to extend residence time relative to Semax, but that intent has not been verified in published work. Researchers should treat any protocol as exploratory and derive comparators from the Semax literature rather than from claims about this compound. This text describes the state of the literature and is not a dosing recommendation.

Evidence Tier

Overall: Tier 3: Anecdotal / self-report

Adamax has essentially no independent evidence base. No peer-reviewed studies, pharmacokinetic parameters, binding data or controlled experiments in any species have been published for the compound itself, and its available characterisation derives from supplier documentation rather than the scientific literature. What support exists is indirect — the Semax scaffold it is built on has a research literature, and adamantane conjugation is a precedented stabilisation strategy — but neither substitutes for data on this molecule. It has no regulatory approval in any jurisdiction and is supplied as unapproved laboratory material.

Source References & Further Reading

Last reviewed: 29 July 2026 · New-U Research Compounds

PubMed: peer-reviewed literature on Adamax

ClinicalTrials.gov: registered studies on Adamax

Adamax: Wikipedia (search)

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Key Characteristics

Synthetic analogue built on the Semax / ACTH(4-10) heptapeptide scaffold

N-terminal acetyl group intended to slow aminopeptidase degradation

C-terminal adamantane cage intended to raise lipophilicity and stability

Adamantane is the same CNS scaffold used in amantadine and memantine

No peer-reviewed literature exists for the compound itself

No published pharmacokinetic, binding or in-vivo comparison data

Characterisation derives from supplier documentation — verify against your own analysis

Research-grade purity: >98% HPLC

Specifications

Class Synthetic Semax / ACTH(4-10) analogue Modifications N-terminal acetylation; C-terminal adamantane conjugate Molecular Formula Not independently established — confirm against batch COA Molecular Weight Not independently established — confirm against batch COA Purity >98% (HPLC) Form Lyophilised powder Route Subcutaneous or intranasal in exploratory protocols Solubility Bacteriostatic water or sterile saline Storage Lyophilised: −20 °C freezer. Reconstituted: 1-6 °C, away from light.

About Adamax: Adamantane-Modified Semax Analogue Research Guide

Adamax belongs to a small family of compounds that take an established research peptide and try to make it last longer. The established peptide here is Semax — a heptapeptide analogue of the ACTH(4-10) fragment, developed within the Russian regulatory-peptide programme, studied over several decades for effects on BDNF expression and TrkB-related neurotrophic signalling. Semax has a genuine research literature. Adamax borrows its core and adds two modifications: acetylation at the amino terminus, and an adamantane cage at the carboxy terminus.

Both modifications are rational medicinal chemistry. N-terminal acetylation is a standard way to block aminopeptidase cleavage. Adamantane is a rigid, highly lipophilic diamondoid hydrocarbon that has a long track record in central-nervous-system drug design — it is the structural core of amantadine and memantine, used in both cases to improve stability and membrane partitioning. Attaching it to a peptide is a reasonable way to attempt the same. But bulky terminal modifications can also disrupt the very pharmacophore they are meant to protect, and whether this conjugate preserves Semax-like activity is not something the published record can currently answer.

That is the honest position on this compound. There is no peer-reviewed literature on Adamax itself, no published pharmacokinetics, no binding data and no controlled comparison against Semax in any species. Its characterisation comes from supplier documentation rather than the scientific record, and researchers should verify material identity against their own analysis and the supplied batch certificate. New-U Research Compounds supplies Adamax as a research-grade lyophilised powder at >98% HPLC purity, strictly for in-vitro and preclinical research use. It is not approved for human therapeutic use in any jurisdiction, and nothing on this page constitutes medical advice or a dosing recommendation.

Semax - Wikipedia

Adrenocorticotropic hormone - Wikipedia

Adamantane - Wikipedia

Brain-derived neurotrophic factor - Wikipedia

Customer Reviews

No customer reviews yet — be the first to share your experience.

More in Cognitive / Neuro

Adamax vs related Cognitive / Neuro compounds

Compound Price Purity spec COA Adamax from $249 >98% HPLC On request Semax from $33 >99% HPLC 2 published batches Selank from $50 >99% HPLC On request

Descriptive catalog comparison for research sourcing decisions — not dosing guidance. All compounds are for laboratory research use only.

More on Adamax

Adamax research guide

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.